As of 2026-03-21, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (11.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.98 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -479.4%.
The range of the Relative Valuation is (10.80) - (11.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 25.2x | 23.4x |
| Forward P/E multiples | 19.6x - 23.0x | 21.0x |
| Fair Price | (10.80) - (11.68) | (11.31) |
| Upside | -462.6% - -491.9% | -479.4% |
| Date | P/E |
| 2026-03-20 | -5.86 |
| 2026-03-19 | -5.96 |
| 2026-03-18 | -6.00 |
| 2026-03-17 | -6.13 |
| 2026-03-16 | -6.19 |
| 2026-03-13 | -6.05 |
| 2026-03-12 | -6.47 |
| 2026-03-11 | -6.98 |
| 2026-03-10 | -6.88 |
| 2026-03-09 | -7.14 |
| 2026-03-06 | -6.98 |
| 2026-03-05 | -7.23 |
| 2026-03-04 | -7.51 |
| 2026-03-03 | -7.25 |
| 2026-03-02 | -7.10 |
| 2026-02-27 | -7.00 |
| 2026-02-26 | -7.00 |
| 2026-02-25 | -6.41 |
| 2026-02-24 | -6.13 |
| 2026-02-23 | -6.02 |
| 2026-02-20 | -6.09 |
| 2026-02-19 | -6.05 |
| 2026-02-18 | -5.86 |
| 2026-02-17 | -5.76 |
| 2026-02-13 | -5.82 |
| 2026-02-12 | -5.94 |
| 2026-02-11 | -6.13 |
| 2026-02-10 | -6.13 |
| 2026-02-09 | -6.11 |
| 2026-02-06 | -6.17 |
| 2026-02-05 | -6.07 |
| 2026-02-04 | -6.43 |
| 2026-02-03 | -6.41 |
| 2026-02-02 | -6.62 |
| 2026-01-30 | -6.60 |
| 2026-01-29 | -6.74 |
| 2026-01-28 | -6.72 |
| 2026-01-27 | -7.47 |
| 2026-01-26 | -7.27 |
| 2026-01-23 | -7.29 |
| 2026-01-22 | -7.53 |
| 2026-01-21 | -7.53 |
| 2026-01-20 | -7.37 |
| 2026-01-16 | -7.71 |
| 2026-01-15 | -7.25 |
| 2026-01-14 | -7.75 |
| 2026-01-13 | -7.90 |
| 2026-01-12 | -7.75 |
| 2026-01-09 | -7.73 |
| 2026-01-08 | -7.57 |